Long-term Testosterone Boosts Urinary, Sexual Function
Remember all the hype of how testosterone administration might increase the risk of prostate cancer and likely increased the risk of cardiovascular events.
After all there is a black box warning on Testosterone products to that effect. Just today my own physician reminded me of those risks.
I have argued vociferously for many years that it was all untrue and finally the truth about the many benefits and real risks have been quantified and published in a peer reviewed major journal. The real risk is not having enough testosterone, not getting treated with testosterone.
Sadly this will be ignored by mainstream medicine again.
Here is what they found.
Men with testosterone deficiency who take long-term testosterone-replacement therapy experience improvements in urinary and sexual function, as well as better quality of life, a registry study suggests. In addition, the data show no increase in risk for adverse events with the treatment.
Following 656 men with hypogonadism for up to 10 years, the researchers found that those who received testosterone therapy to physiological levels had significantly fewer urinary symptoms and were less likely to have erectile dysfunction, despite increases in prostate volumes.
The study, which was a collaboration between researchers from Boston University School of Medicine and Public Health and urologists in Germany, was published online in the Journal of Urology on July 18.
The results show that testosterone therapy “is well-tolerated, with progressive and sustained improvement in urinary and sexual function and overall improvement in quality of life,” lead author Abdulmaged Traish, PhD, department of urology, Boston University School of Medicine, Boston, Massachusetts
The team also found that there were significant improvements in erectile function among men given testosterone therapy (P < .0001), with the proportion of men with no erectile dysfunction increasing from 17.1% to 74.4%. Controls experienced a nonsignificant decrease in erectile function.
“There were no major adverse events in the testosterone-therapy group, compared with five deaths, eight nonfatal strokes, and eight nonfatal myocardial infarctions in the control group.”
WHICH GROUP DO YOU WANT TO BE IN?